Leukemia

Analysis of Thrombotic Events in Patients Receiving Ibrutinib

By

Sharon Ben Barouch, MD

Publish Date October 17, 2019

Researchers found a low incidence of thrombotic events in patients receiving ibrutinib, though some patients still experienced bleeding.

Factors Predict Low BMD in Pediatric Blood Cancer Survivors

Publish Date October 8, 2019

Low bone mineral density detected during guideline-recommended dual-energy X-ray absorptiometry.

A New Era: Drug Development for Acute Myeloid Leukemia After the Approval of Venetoclax

By

Marielle Fares, PharmD

Publish Date September 30, 2019

Although the 7 + 3 regimen has been the standard of care for acute myeloid leukemia for decades, it may be time to reassess its value and utility.

The Nurse’s Role in Childhood Leukemia From Disease Recognition to Survivorship Care

By

Bette Weinstein Kaplan

Publish Date September 26, 2019

An overview of the nurse’s role when a diagnosis of leukemia is made for a child.

Many Older Patients With AML Not Receiving Active Treatment

Publish Date September 23, 2019

No active treatment more likely with older age, lower household income, unmarried status, comorbidities.

Leukemia Clinical Trials

Clinical Trial: Molecular Epidemiology of Childhood Leukemia (Aka The California Childhood Leukemia Study) (CCLS)

Clinical trial focusing on the molecular epidemiology of childhood leukemia. Molecular Epidemiology of Childhood Leukemia (Aka The California Childhood Leukemia Study) (CCLS)

Clinical Trial: Genetic Study of Chronic Lymphocytic Leukemia Families

Clinical trial focusing on genetics and chronic lymphocytic leukemia. Genetic Study of Chronic Lymphocytic Leukemia Families

Clinical Trial: Banking of Chronic Lymphocytic Leukemia Tumor Cells for Vaccine Generation

Clinical trial focusing on vaccine generation from chronic lymphocytic leukemia tumor cells. Banking of Chronic Lymphocytic Leukemia Tumor Cells for Vaccine Generation

Clinical Trial: Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia

Clinical trial focusing on GNKG168. Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia

Clinical Trial: Study of Carfilzomib in Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic Leukemia (PLL)

Clinical trial focusing on carfilzomib Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic Leukemia (PLL). Study of Carfilzomib in Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic Leukemia (PLL) .